RAPT stock RAPT Therapeutics (NASDAQ) at $58.02 intraday 04 Mar 2026: earnings catalyst ahead

RAPT stock trades at $58.02 intraday on 04 Mar 2026 ahead of an earnings release scheduled for 05 Mar 2026. The market is pricing in clinical and messaging milestones more than revenue, given RAPT Therapeutics, Inc.’s clinical-stage profile on the NASDAQ in the United States. Key intraday stats: volume 10,846,697, market cap $959.51M, and EPS -11.66. We note the company’s lead assets, RPT193 and FLX475, remain the likely drivers in tomorrow’s call. For live quote and company context, see our Meyka stock page and the latest market coverage MarketBeat and Investing.com. Meyka AI provides this AI-powered market analysis to frame risks and possible moves